SlideShare a Scribd company logo
1 of 38
312 PHT 1
Pharmaceutical
Suspension
Presented & Written By: *Rahul Pal, Prachi Pandey
*Department of Pharmaceutics, NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan, 303121,
India.
M. Pharm (Pharmaceutics)
DEFINITION
 A Pharmaceutical suspension is a coarse dispersion in
which internal phase is dispersed uniformly throughout the external phase.
 The internal phase consisting of insoluble solid
particles having a specific range of size which is maintained uniformly
throughout the suspending vehicle with aid of single or combination of
suspending agent.
 The external phase (suspending medium) is generally
aqueous in some instance, may be an organic or oily liquid for non oral use.
312 PHT 2
CLASSIFICATION
Based On General Classes
Oral suspension
Externally applied suspension
Parenteral suspension
Based On Proportion Of Solid Particles
Dilute suspension (2 to10%w/v solid)
Concentrated suspension (50%w/v solid)
Based On Electrokinetic Nature Of Solid Particles
Flocculated suspension
Deflocculated suspension
Based On Size Of Solid Particles
Colloidal suspension (< 1 micron)
Coarse suspension (>1 micron)
Nano suspension (10 ng)
312 PHT 3
ADVANTAGES
Suspension can improve chemical stability of certain drug. E.g. Procaine
penicillin G
Drug in suspension exhibits higher rate of bioavailability than other dosage
forms. bioavailability is in following order,
Solution > Suspension > Capsule > Compressed Tablet > Coated tablet
Duration and onset of action can be controlled. E.g. Protamine Zinc-Insulin
suspension
Suspension can mask the unpleasant/ bitter taste of drug. E.g. Chloramphenicol
palmitate
312 PHT 4
DISADVANTAGES
1. Physical stability, sedimentation and compaction can causes problems.
2. It is bulky sufficient care must be taken during handling and transport.
3. It is difficult to formulate
4. Uniform and accurate dose can not be achieved unless suspension are packed
in unit dosage form
312 PHT 5
Features Desired In Pharmaceutical
Suspensions
1. The suspended particles should not settle rapidly and sediment produced, must
be easily re-suspended by the use of moderate amount of shaking.
2. It should be easy to pour yet not watery and no grittiness.
3. It should have pleasing odour, colour and palatability.
4. Good syringeability.
5. It should be physically, chemically and microbiologically stable.
6. Parenteral/ophthalmic suspension should be sterilizable.
312 PHT 6
APPLICATIONS
1. Suspension is usually applicable for drug which is insoluble or poorly soluble. E.g. Prednisolone suspension
2. To prevent degradation of drug or to improve stability of drug. E.g. Oxytetracycline suspension
3. To mask the taste of bitter of unpleasant drug, E.g. Chloramphenicol palmitate suspension
4. Suspension of drug can be formulated for topical application e.g. Calamine lotion.
5. Suspension can be formulated for parentral application in order to control rate of drug absorption, E.g. penicillin
procaine
6. Vaccines as a immunizing agent are often formulated as suspension, E.g. Cholera vaccine
7. X-ray contrast agent are also formulated as suspension, E.g. Barium sulphate for examination of alimentary tract
312 PHT 7
Theory of Suspensions
Sedimentation Behaviour
Sedimentation means settling of particle or floccules
occur under gravitational force in liquid dosage form.
Theory of Sedimentation
Velocity of sedimentation expressed by Stoke’s equation
312 PHT 8
Where, vsed. = sedimentation velocity in cm / sec
d = Diameterof particle
r = radius of particle
ρ s= density of disperse phase
ρ o= density of disperse media
g = acceleration due to gravity
Ξ· = viscosity of disperse medium in poise
312 PHT 9
Factors Affecting Sedimentation
Particle size diameter (d)
V Ξ± d 2
Sedimentation velocity (v) is directly proportional to the square of diameter of particle.
Density difference between dispersed phase and dispersion media (ρs - ρo)
V α (ρ s - ρo)
Generally, particle density is greater than dispersion medium but, in certain cases particle density is
less than dispersed phase, so suspended particle floats & is difficult to distribute uniformly in the
vehicle.
If density of the dispersed phase and dispersion medium are equal, the rate of settling becomes zero.
312 PHT 10
Viscosity of dispersion medium (Ξ· )
V Ξ± 1/ Ξ·o
Sedimentation velocity is inversely proportional to
viscosity of dispersion medium.
So increase in viscosity of medium, decreases settling, so the particles
achieve good dispersion system but greater increase
in viscosity gives rise to problems like pouring, syringibility and
redispersibility of suspensoin.
312 PHT 11
Advantages and Disadvantages due to
viscosity of medium
Advantages
High viscosity inhibits the crystal growth.
High viscosity prevents the transformation of metastable crystal to stable crystal.
High viscosity enhances the physical stability.
Disadvantages
High viscosity hinders the re-dispersibility of the sediments
High viscosity retards the absorption of the drug.
High viscosity creates problems in handling of the material during manufacturing.
312 PHT 12
I- Sedimentation Parameters
Two important parameters are considered:
Sedimentation volume (F) or height (H) for flocculated suspensions
F = V u / VO -------------- (A)
Where, Vu = final or ultimate volume of sediment
VO = original volume of suspension before settling.
Sedimentation volume is a ratio of the final or
ultimate volume of sediment (Vu) to the original volume of sediment (VO) before settling.
Sedimentation volume can have values ranging from less than 1 to greater than1; F is normally less
than 1.
F=1,such product is said to be in flocculation equilibrium, and show no clear supernatant on standing
312 PHT 13
312 PHT 14
Fig.1: Suspensions quantified by sedimentation volume (f)
Degree of flocculation (Ξ²)
It is a very useful parameter for flocculation
312 PHT 15
The Sedimentation Behavior of Flocculated
and Deflocculated Suspensions:
Flocculated Suspensions
In flocculated suspension, formed flocks (loose aggregates) will cause increase in
sedimentation rate due to increase in size of sedimenting particles. Hence,
flocculated suspensions sediment more rapidly.
Here, the sedimentation depends not only on the size of the flocs but also on the
porosity of flocks. In flocculated suspension the loose structure of the rapidly
sedimenting flocs tends to preserve in the sediment, which contains an
appreciable amount of entrapped liquid. The volume of final sediment is thus
relatively large and is easily redispersed by agitation.
312 PHT 16
312 PHT 17
Fig 2: Sedimentation behaviour of flocculated and deflocculated suspensions
Deflocculated suspensions
In deflocculated suspension, individual particles are settling, so rate of
sedimentation is slow which prevents entrapping of liquid medium which makes
it difficult to re-disperse by agitation.
This phenomenon also called β€˜cracking’ or β€˜claying’. In deflocculated suspension
larger particles settle fast and smaller remain in supernatant liquid so supernatant
appears cloudy whereby in flocculated suspension, even the smallest particles are
involved in flocs, so the supernatant does not appear cloudy.
312 PHT 18
Flocculating Agents
Flocculating agents decreases zeta potential of the suspended charged particle and thus cause
aggregation (flock formation) of the particles.
Examples of flocculating agents are:
Neutral electrolytes such as KCl, NaCl.
Surfactants
Polymeric flocculating agents
Sulfate, citrates, phosphates salts
Neutral electrolytes e.g. NaCl, KCl besides acting as flocculating agents, also decreases
interfacial tension of the surfactant solution. If the particles are having less surface charge then
monovalent ions are sufficient to cause flocculation e.g. steroidal drugs.
For highly charged particles e.g. insoluble polymers and poly-electrolytes species, di or trivalent
flocculating agents are used.
312 PHT 19
Method of Floccules Formation
The different methods used to form floccules are mentioned below:
1 . Electrolytes
Electrolytes decrease electrical barrier between the particles and bring them together to
form floccules. They reduce zeta potential near to zero value that results in formation of
bridge between adjacent particles, which lines them together in a loosely arranged
structure.
If we disperse particles of bismuth subnitrate in water we find that based on
electrophoretic mobility potential because of the strong force of repulsion between
adjacent particles, the system is peptized or deflocculated. By preparing series of bismuth
subnitrate suspensions containing increasing concentration of monobasic potassium
phosphate co-relation between apparent zeta potential and sedimentation volume, caking,
and flocculation can be
demonstrated.
312 PHT 20
312 PHT 21
Fig 3: Caking diagram, showing the flocculation of a bismuth subnitrate
suspension by means of the flocculating agent.
The addition of monobasic potassium phosphate to the suspended bismuth
subnitrate particles causes the positive zeta potential to decrease owing to the
adsorption of negatively charged phosphate anion.
With continued addition of the electrolyte, the zeta potential eventually falls to
zero and then increases in negative directions.
Only when zeta potential becomes sufficiently negative to affect potential does
the sedimentation volume start to fall.
Finally, the absence of caking in the suspensions correlates with the maximum
sedimentation volume, which, as stated previously, reflects the amount of
flocculation.
312 PHT 22
2. SURFACTANT
Both ionic and non-ionic surfactants can be used to bring about flocculation of
suspended particles.
 Optimum concentration is necessary because these compounds also act as
wetting agents to achieve dispersion.
 Optimum concentrations of surfactants bring down the surface free energy by
reducing the surface tension between liquid medium and solid particles. This
tends to form closely packed agglomerates.
 The particles possessing less surface free energy are attracted towards to each
other by van der-waals forces and forms loose agglomerates.
312 PHT 23
3. POLYMERS
Polymers possess long chain in their structures.
Starch, alginates, cellulose derivatives, carbomers, tragacanth etc.
The part of the long chain is adsorbed on the surface of the particles and
remaining part projecting out into the dispersed medium.
Bridging between these later portions, also leads to the formation of flocs.
312 PHT 24
Viscosity of Suspensions
Viscosity of suspensions is of great importance for stability and pourability of suspensions. As we know
suspensions have least physical stability amongst all dosage forms due to sedimentation and cake formation.
So as the viscosity of the dispersion medium increases, the terminal settling velocity decreases thus the
dispersed phase settle at a slower rate and they remain dispersed for longer time yielding higher stability to
the suspension.
On the other hand as the viscosity of the suspension increases, it’s pourability decreases and inconvenience
to the patients for dosing increases.
Thus, the viscosity of suspension should be maintained within optimum range to yield stable and easily
pourable suspensions.
312 PHT 25
Different Approaches To Increase The
Viscosity of Suspensions
Various approaches have been suggested to enhance the viscosity of suspensions.
Few of them are as follows:
1. Viscosity Enhancers
Some natural gums (acacia, tragacanth), cellulose derivatives (sodium CMC,
methyl cellulose), clays(bentonite, veegum), carbomers, colloidal silicon dioxide
(Aerosil), and sugars (glucose, fructose) are used to enhance the viscosity of the
dispersion medium. They are known as suspending agents.
312 PHT 26
312 PHT 27
List of Suspending Agents
Alginates
Methylcellulose
Hydroxyethylcellulose
Carboxymethylcellulose
Sodium Carboxymethylcellulose
Microcrystalline cellulose
Acacia, Tragacanth, Xanthan gum
Bentonite
Carbomer
Powdered cellulose
Gelatin
2. Co-solvents
Some solvents which themselves have high viscosity are used as co-solvents to enhance
the viscosity of dispersion medium:
Glycerol, propylene glycol, sorbitol.
Most suspending agents perform two functions i.e. besides acting as a suspending agent
they also imparts viscosity to the solution. Suspending agents form film around particle
and decrease interparticle attraction.
A good suspension should have well developed
thixotropy.
At rest the solution is sufficient viscous to prevent sedimentation and thus aggregation or
caking of the particles. When agitation is applied the viscosity is reduced and provide
good flow characteristic from the mouth of bottle.
312 PHT 28
Thixotropy
Thixotropy is defined as the isothermal
slow reversible conversion of gel to sol. Thixotropic substances on applying
shear stress convert to sol(fluid) and on standing they slowly turn to gel
(semisolid).
312 PHT 29
Other Formulation Aspects
Introduction
A perfect suspension is one, which provides content uniformity. The formulator
must encounter important problems regarding particle size distribution, specific
surface area, inhibition of crystal growth and changes in the polymorphic form.
The formulator must ensure that these and other properties should not change
after long term storage and do not adversely affect the performance of suspension.
Choice of pH, particle size, viscosity, flocculation, taste, color and odor are some
of the most important factors that must be controlled at the time of formulation.
Formulation Components
The various components, which are used in suspension formulation, are as
follows.
312 PHT 30
ο‚· Components Function
API Active drug substances
Wetting agents They are added to disperse solids in continuous liquid
phase.
Flocculating agents They are added to floc the drug particles
Thickeners They are added to increase the viscosity of suspension.
Buffers
and pH adjusting agents
They are added to stabilize the suspension to a desired
pH range.
Osmotic agents They are added to adjust osmotic pressure comparable
to biological fluid.
Coloring agents They are added to impart desired color to suspension
and improve elegance.
Preservatives They are added to prevent microbial growth.
External liquid vehicle They are added to construct structure of the final
suspension.
312 PHT 31
Wetting Agents
Hydrophilic materials are easily wetted by water while hydrophobic materials are not. However
hydrophobic materials are easily wetted by non-polar liquids. The extent of wetting by water is
dependent on the hydrophillicity of the materials. If the material is more hydrophilic it finds less
difficulty in wetting by water. Inability of wetting reflects the higher interfacial tension between
material and liquid. The interfacial tension must be reduced so that air is displaced from the solid
surface by liquid.
Non-ionic surfactants are most commonly used as wetting agents in pharmaceutical suspension.
Non-ionic surfactants having HLB value between 7-10 are best as wetting agents. High HLB
surfactants act as foaming agents. The concentration used is less than 0.5 %. A high amount of
surfactant causes solubilization of drug particles and causes stability problem.
Ionic surfactants are not generally used because they are not compatible with many adjuvant and
causes change in pH.
312 PHT 32
Surfactants
Surfactants decrease the interfacial tension between drug particles and liquid and thus liquid is penetrated in the
pores of drug particle displacing air from them and thus ensures wetting.
Surfactants in optimum concentration facilitate dispersion of particles. Generally we use non-ionic surfactants but
ionic surfactants can also be used depending upon certain conditions.
Disadvantages of surfactants are that they have foaming tendencies.
Further they are bitter in taste. Some surfactants such as polysorbate 80 interact with preservatives such as methyl
paraben and reduce antimicrobial activity.
All surfactants are bitter except Pluronics and
Poloxamers.
Polysorbate 80 is most widely used surfactant both for parenteral and oral suspension formulation.
Polysorbate 80 is also adsorbed on drug particle and decreases its zeta potential. This effect of polysorbate80
stabilizes the suspension.
Polysorbate 80 stabilized suspensions through steric mechanism. At low concentration of polysorbate 80,only
partial stabilization of suspension was observed.
312 PHT 33
Hydrophilic Colloids
Hydrophilic colloids coat hydrophobic drug particles
in one or more than one layer. This will provide hydrophillicity to drug particles
and facilitate wetting.
They cause deflocculation of suspension because force of attraction is declined.
e.g. acacia, tragacanth, alginates, guar gum, pectin, gelatin, wool fat, egg yolk,
bentonite, Veegum, Methylcellulose etc.
312 PHT 34
Solvents
The most commonly used solvents used are alcohol,
glycerin, polyethylene glycol and polypropylene glycol. The mechanism by
which they provide wetting is that they are miscible with water and reduce liquid
air interfacial tension. Liquid penetrates in individual particle and facilitates
wetting.
312 PHT 35
Quality Control of Suspensions
The following tests are carried out in the final quality control of suspension:
Appearance Color, odor and taste
Physical characteristics such as particle size determination and microscopic photography for crystal growth
Sedimentation rate and
Zeta Potential measurement
Sedimentation volume
Redispersibility and Centrifugation tests
Rheological measurement
Stress test
pH
Freeze-Thaw temperature cycling
Compatibility with container and cap liner
312 PHT 36
Ideal Requirements of Packaging
Material
It should be inert.
It should effectively preserve the product from light, air, and other contamination
through shelf life.
It should be cheap.
It should effectively deliver the product without any difficulty.
312 PHT 37
312 PHT 38

More Related Content

Similar to Pharmaceutical Suspension Dosage Form (PPT)

Pharmaceutical oral Suspension
Pharmaceutical oral SuspensionPharmaceutical oral Suspension
Pharmaceutical oral SuspensionTehmina Adnan
Β 
L1-4 suspension.pdf for pharmhacists and
L1-4 suspension.pdf for pharmhacists andL1-4 suspension.pdf for pharmhacists and
L1-4 suspension.pdf for pharmhacists andGulyChwas
Β 
Pharmaceutical suspension
Pharmaceutical suspensionPharmaceutical suspension
Pharmaceutical suspensionIstiaque Ahmed
Β 
coarse-dispersions-suspension.pptx
coarse-dispersions-suspension.pptxcoarse-dispersions-suspension.pptx
coarse-dispersions-suspension.pptxarti176701
Β 
coarse-dispersions-suspension.pptx
coarse-dispersions-suspension.pptxcoarse-dispersions-suspension.pptx
coarse-dispersions-suspension.pptxarti176701
Β 
suspension ppt.pptx
suspension ppt.pptxsuspension ppt.pptx
suspension ppt.pptxanamhameed4
Β 
Pharmaceutical Suspension
Pharmaceutical SuspensionPharmaceutical Suspension
Pharmaceutical SuspensionParag Jain
Β 
Suspension sneha patel
Suspension sneha patelSuspension sneha patel
Suspension sneha patelSneha Patel
Β 
pharmaceutical suspension-ppt
pharmaceutical suspension-pptpharmaceutical suspension-ppt
pharmaceutical suspension-pptfaysalahmed35
Β 
Physical stability of suspensions and emulsion, role of zeta potential in sta...
Physical stability of suspensions and emulsion, role of zeta potential in sta...Physical stability of suspensions and emulsion, role of zeta potential in sta...
Physical stability of suspensions and emulsion, role of zeta potential in sta...AmitSahu546305
Β 
Suspensions
SuspensionsSuspensions
SuspensionsIndhu G.P
Β 
Pharmaceutics - suspension
Pharmaceutics -  suspensionPharmaceutics -  suspension
Pharmaceutics - suspensionAreej Abu Hanieh
Β 
Pharmaceutical suspensions sb
Pharmaceutical suspensions sbPharmaceutical suspensions sb
Pharmaceutical suspensions sbMirza Salman Baig
Β 
7. Introduction to different dosage form part 7.ppt
7. Introduction to different dosage form part 7.ppt7. Introduction to different dosage form part 7.ppt
7. Introduction to different dosage form part 7.pptParimal Hadge
Β 
Suspensionx
SuspensionxSuspensionx
Suspensionxiqra mobeen
Β 

Similar to Pharmaceutical Suspension Dosage Form (PPT) (20)

suspensions
 suspensions suspensions
suspensions
Β 
Suspension.
Suspension.Suspension.
Suspension.
Β 
Pharmaceutical oral Suspension
Pharmaceutical oral SuspensionPharmaceutical oral Suspension
Pharmaceutical oral Suspension
Β 
L1-4 suspension.pdf for pharmhacists and
L1-4 suspension.pdf for pharmhacists andL1-4 suspension.pdf for pharmhacists and
L1-4 suspension.pdf for pharmhacists and
Β 
Pharmaceutical suspension
Pharmaceutical suspensionPharmaceutical suspension
Pharmaceutical suspension
Β 
Suspension
SuspensionSuspension
Suspension
Β 
coarse-dispersions-suspension.pptx
coarse-dispersions-suspension.pptxcoarse-dispersions-suspension.pptx
coarse-dispersions-suspension.pptx
Β 
coarse-dispersions-suspension.pptx
coarse-dispersions-suspension.pptxcoarse-dispersions-suspension.pptx
coarse-dispersions-suspension.pptx
Β 
suspension ppt.pptx
suspension ppt.pptxsuspension ppt.pptx
suspension ppt.pptx
Β 
SUSPENSIONS.ppt
SUSPENSIONS.pptSUSPENSIONS.ppt
SUSPENSIONS.ppt
Β 
Pharmaceutical Suspension
Pharmaceutical SuspensionPharmaceutical Suspension
Pharmaceutical Suspension
Β 
Suspension sneha patel
Suspension sneha patelSuspension sneha patel
Suspension sneha patel
Β 
pharmaceutical suspension-ppt
pharmaceutical suspension-pptpharmaceutical suspension-ppt
pharmaceutical suspension-ppt
Β 
Physical stability of suspensions and emulsion, role of zeta potential in sta...
Physical stability of suspensions and emulsion, role of zeta potential in sta...Physical stability of suspensions and emulsion, role of zeta potential in sta...
Physical stability of suspensions and emulsion, role of zeta potential in sta...
Β 
Suspensions
SuspensionsSuspensions
Suspensions
Β 
Suspension
SuspensionSuspension
Suspension
Β 
Pharmaceutics - suspension
Pharmaceutics -  suspensionPharmaceutics -  suspension
Pharmaceutics - suspension
Β 
Pharmaceutical suspensions sb
Pharmaceutical suspensions sbPharmaceutical suspensions sb
Pharmaceutical suspensions sb
Β 
7. Introduction to different dosage form part 7.ppt
7. Introduction to different dosage form part 7.ppt7. Introduction to different dosage form part 7.ppt
7. Introduction to different dosage form part 7.ppt
Β 
Suspensionx
SuspensionxSuspensionx
Suspensionx
Β 

More from Prachi Pandey

Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxPrachi Pandey
Β 
Niosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptxNiosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptxPrachi Pandey
Β 
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); Advanceme...
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); Advanceme...𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); Advanceme...
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); Advanceme...Prachi Pandey
Β 
The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...Prachi Pandey
Β 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...Prachi Pandey
Β 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfPrachi Pandey
Β 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPrachi Pandey
Β 
Partition Coefficient Determination.pptx
Partition Coefficient Determination.pptxPartition Coefficient Determination.pptx
Partition Coefficient Determination.pptxPrachi Pandey
Β 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Prachi Pandey
Β 
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Prachi Pandey
Β 
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...Prachi Pandey
Β 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Prachi Pandey
Β 
ProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptxProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptxPrachi Pandey
Β 
IMPORTSOFDRUGS.pptx
IMPORTSOFDRUGS.pptxIMPORTSOFDRUGS.pptx
IMPORTSOFDRUGS.pptxPrachi Pandey
Β 
MicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptxMicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptxPrachi Pandey
Β 
Protein and Peptide.pptx
Protein and Peptide.pptxProtein and Peptide.pptx
Protein and Peptide.pptxPrachi Pandey
Β 
NanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdfNanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdfPrachi Pandey
Β 
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptxTOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptxPrachi Pandey
Β 
IntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxIntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxPrachi Pandey
Β 
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptxBiostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptxPrachi Pandey
Β 

More from Prachi Pandey (20)

Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
Β 
Niosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptxNiosomes (Formulation and evaluation).pptx
Niosomes (Formulation and evaluation).pptx
Β 
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); Advanceme...
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); Advanceme...𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); Advanceme...
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); Advanceme...
Β 
The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...The Application of Response Surface Methodology (RSM) In the Computational Op...
The Application of Response Surface Methodology (RSM) In the Computational Op...
Β 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
Β 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
Β 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
Β 
Partition Coefficient Determination.pptx
Partition Coefficient Determination.pptxPartition Coefficient Determination.pptx
Partition Coefficient Determination.pptx
Β 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Β 
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_I_General Research Methodology M. Pharm (IIIrd Sem.)
Β 
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
THE CURRENT STATUS IN MUCOSALDRUG DELIVERY SYSTEM (MDDS)AND FUTURE PROSPECTUS...
Β 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Β 
ProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptxProductManagement-InventroyManagementandControls.pptx
ProductManagement-InventroyManagementandControls.pptx
Β 
IMPORTSOFDRUGS.pptx
IMPORTSOFDRUGS.pptxIMPORTSOFDRUGS.pptx
IMPORTSOFDRUGS.pptx
Β 
MicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptxMicrospheresPreparationandEvaluations.pptx
MicrospheresPreparationandEvaluations.pptx
Β 
Protein and Peptide.pptx
Protein and Peptide.pptxProtein and Peptide.pptx
Protein and Peptide.pptx
Β 
NanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdfNanoTechnology3DEuropeanChemicalBulletin.pdf
NanoTechnology3DEuropeanChemicalBulletin.pdf
Β 
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptxTOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
TOTAL QUALITY MANAGEMENT, BUDGET & COST CONTROL.pptx
Β 
IntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptxIntroductiontoPharmacyPharmaceutics.pptx
IntroductiontoPharmacyPharmaceutics.pptx
Β 
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptxBiostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
Biostatistics_Unit_II_ResearchMethodologyBiostatistics.pptx
Β 

Recently uploaded

ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
Β 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxEyham Joco
Β 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersSabitha Banu
Β 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
Β 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
Β 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerunnathinaik
Β 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
Β 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
Β 
18-04-UA_REPORT_MEDIALITERAΠ‘Y_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAΠ‘Y_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAΠ‘Y_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAΠ‘Y_INDEX-DM_23-1-final-eng.pdfssuser54595a
Β 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
Β 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
Β 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
Β 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
Β 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
Β 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
Β 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
Β 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
Β 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
Β 

Recently uploaded (20)

ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
Β 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptx
Β 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginners
Β 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
Β 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
Β 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developer
Β 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
Β 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
Β 
18-04-UA_REPORT_MEDIALITERAΠ‘Y_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAΠ‘Y_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAΠ‘Y_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAΠ‘Y_INDEX-DM_23-1-final-eng.pdf
Β 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
Β 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
Β 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
Β 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
Β 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
Β 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Β 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
Β 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
Β 
Model Call Girl in Tilak Nagar Delhi reach out to us at πŸ”9953056974πŸ”
Model Call Girl in Tilak Nagar Delhi reach out to us at πŸ”9953056974πŸ”Model Call Girl in Tilak Nagar Delhi reach out to us at πŸ”9953056974πŸ”
Model Call Girl in Tilak Nagar Delhi reach out to us at πŸ”9953056974πŸ”
Β 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
Β 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
Β 

Pharmaceutical Suspension Dosage Form (PPT)

  • 1. 312 PHT 1 Pharmaceutical Suspension Presented & Written By: *Rahul Pal, Prachi Pandey *Department of Pharmaceutics, NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan, 303121, India. M. Pharm (Pharmaceutics)
  • 2. DEFINITION  A Pharmaceutical suspension is a coarse dispersion in which internal phase is dispersed uniformly throughout the external phase.  The internal phase consisting of insoluble solid particles having a specific range of size which is maintained uniformly throughout the suspending vehicle with aid of single or combination of suspending agent.  The external phase (suspending medium) is generally aqueous in some instance, may be an organic or oily liquid for non oral use. 312 PHT 2
  • 3. CLASSIFICATION Based On General Classes Oral suspension Externally applied suspension Parenteral suspension Based On Proportion Of Solid Particles Dilute suspension (2 to10%w/v solid) Concentrated suspension (50%w/v solid) Based On Electrokinetic Nature Of Solid Particles Flocculated suspension Deflocculated suspension Based On Size Of Solid Particles Colloidal suspension (< 1 micron) Coarse suspension (>1 micron) Nano suspension (10 ng) 312 PHT 3
  • 4. ADVANTAGES Suspension can improve chemical stability of certain drug. E.g. Procaine penicillin G Drug in suspension exhibits higher rate of bioavailability than other dosage forms. bioavailability is in following order, Solution > Suspension > Capsule > Compressed Tablet > Coated tablet Duration and onset of action can be controlled. E.g. Protamine Zinc-Insulin suspension Suspension can mask the unpleasant/ bitter taste of drug. E.g. Chloramphenicol palmitate 312 PHT 4
  • 5. DISADVANTAGES 1. Physical stability, sedimentation and compaction can causes problems. 2. It is bulky sufficient care must be taken during handling and transport. 3. It is difficult to formulate 4. Uniform and accurate dose can not be achieved unless suspension are packed in unit dosage form 312 PHT 5
  • 6. Features Desired In Pharmaceutical Suspensions 1. The suspended particles should not settle rapidly and sediment produced, must be easily re-suspended by the use of moderate amount of shaking. 2. It should be easy to pour yet not watery and no grittiness. 3. It should have pleasing odour, colour and palatability. 4. Good syringeability. 5. It should be physically, chemically and microbiologically stable. 6. Parenteral/ophthalmic suspension should be sterilizable. 312 PHT 6
  • 7. APPLICATIONS 1. Suspension is usually applicable for drug which is insoluble or poorly soluble. E.g. Prednisolone suspension 2. To prevent degradation of drug or to improve stability of drug. E.g. Oxytetracycline suspension 3. To mask the taste of bitter of unpleasant drug, E.g. Chloramphenicol palmitate suspension 4. Suspension of drug can be formulated for topical application e.g. Calamine lotion. 5. Suspension can be formulated for parentral application in order to control rate of drug absorption, E.g. penicillin procaine 6. Vaccines as a immunizing agent are often formulated as suspension, E.g. Cholera vaccine 7. X-ray contrast agent are also formulated as suspension, E.g. Barium sulphate for examination of alimentary tract 312 PHT 7
  • 8. Theory of Suspensions Sedimentation Behaviour Sedimentation means settling of particle or floccules occur under gravitational force in liquid dosage form. Theory of Sedimentation Velocity of sedimentation expressed by Stoke’s equation 312 PHT 8
  • 9. Where, vsed. = sedimentation velocity in cm / sec d = Diameterof particle r = radius of particle ρ s= density of disperse phase ρ o= density of disperse media g = acceleration due to gravity Ξ· = viscosity of disperse medium in poise 312 PHT 9
  • 10. Factors Affecting Sedimentation Particle size diameter (d) V Ξ± d 2 Sedimentation velocity (v) is directly proportional to the square of diameter of particle. Density difference between dispersed phase and dispersion media (ρs - ρo) V Ξ± (ρ s - ρo) Generally, particle density is greater than dispersion medium but, in certain cases particle density is less than dispersed phase, so suspended particle floats & is difficult to distribute uniformly in the vehicle. If density of the dispersed phase and dispersion medium are equal, the rate of settling becomes zero. 312 PHT 10
  • 11. Viscosity of dispersion medium (Ξ· ) V Ξ± 1/ Ξ·o Sedimentation velocity is inversely proportional to viscosity of dispersion medium. So increase in viscosity of medium, decreases settling, so the particles achieve good dispersion system but greater increase in viscosity gives rise to problems like pouring, syringibility and redispersibility of suspensoin. 312 PHT 11
  • 12. Advantages and Disadvantages due to viscosity of medium Advantages High viscosity inhibits the crystal growth. High viscosity prevents the transformation of metastable crystal to stable crystal. High viscosity enhances the physical stability. Disadvantages High viscosity hinders the re-dispersibility of the sediments High viscosity retards the absorption of the drug. High viscosity creates problems in handling of the material during manufacturing. 312 PHT 12
  • 13. I- Sedimentation Parameters Two important parameters are considered: Sedimentation volume (F) or height (H) for flocculated suspensions F = V u / VO -------------- (A) Where, Vu = final or ultimate volume of sediment VO = original volume of suspension before settling. Sedimentation volume is a ratio of the final or ultimate volume of sediment (Vu) to the original volume of sediment (VO) before settling. Sedimentation volume can have values ranging from less than 1 to greater than1; F is normally less than 1. F=1,such product is said to be in flocculation equilibrium, and show no clear supernatant on standing 312 PHT 13
  • 14. 312 PHT 14 Fig.1: Suspensions quantified by sedimentation volume (f)
  • 15. Degree of flocculation (Ξ²) It is a very useful parameter for flocculation 312 PHT 15
  • 16. The Sedimentation Behavior of Flocculated and Deflocculated Suspensions: Flocculated Suspensions In flocculated suspension, formed flocks (loose aggregates) will cause increase in sedimentation rate due to increase in size of sedimenting particles. Hence, flocculated suspensions sediment more rapidly. Here, the sedimentation depends not only on the size of the flocs but also on the porosity of flocks. In flocculated suspension the loose structure of the rapidly sedimenting flocs tends to preserve in the sediment, which contains an appreciable amount of entrapped liquid. The volume of final sediment is thus relatively large and is easily redispersed by agitation. 312 PHT 16
  • 17. 312 PHT 17 Fig 2: Sedimentation behaviour of flocculated and deflocculated suspensions
  • 18. Deflocculated suspensions In deflocculated suspension, individual particles are settling, so rate of sedimentation is slow which prevents entrapping of liquid medium which makes it difficult to re-disperse by agitation. This phenomenon also called β€˜cracking’ or β€˜claying’. In deflocculated suspension larger particles settle fast and smaller remain in supernatant liquid so supernatant appears cloudy whereby in flocculated suspension, even the smallest particles are involved in flocs, so the supernatant does not appear cloudy. 312 PHT 18
  • 19. Flocculating Agents Flocculating agents decreases zeta potential of the suspended charged particle and thus cause aggregation (flock formation) of the particles. Examples of flocculating agents are: Neutral electrolytes such as KCl, NaCl. Surfactants Polymeric flocculating agents Sulfate, citrates, phosphates salts Neutral electrolytes e.g. NaCl, KCl besides acting as flocculating agents, also decreases interfacial tension of the surfactant solution. If the particles are having less surface charge then monovalent ions are sufficient to cause flocculation e.g. steroidal drugs. For highly charged particles e.g. insoluble polymers and poly-electrolytes species, di or trivalent flocculating agents are used. 312 PHT 19
  • 20. Method of Floccules Formation The different methods used to form floccules are mentioned below: 1 . Electrolytes Electrolytes decrease electrical barrier between the particles and bring them together to form floccules. They reduce zeta potential near to zero value that results in formation of bridge between adjacent particles, which lines them together in a loosely arranged structure. If we disperse particles of bismuth subnitrate in water we find that based on electrophoretic mobility potential because of the strong force of repulsion between adjacent particles, the system is peptized or deflocculated. By preparing series of bismuth subnitrate suspensions containing increasing concentration of monobasic potassium phosphate co-relation between apparent zeta potential and sedimentation volume, caking, and flocculation can be demonstrated. 312 PHT 20
  • 21. 312 PHT 21 Fig 3: Caking diagram, showing the flocculation of a bismuth subnitrate suspension by means of the flocculating agent.
  • 22. The addition of monobasic potassium phosphate to the suspended bismuth subnitrate particles causes the positive zeta potential to decrease owing to the adsorption of negatively charged phosphate anion. With continued addition of the electrolyte, the zeta potential eventually falls to zero and then increases in negative directions. Only when zeta potential becomes sufficiently negative to affect potential does the sedimentation volume start to fall. Finally, the absence of caking in the suspensions correlates with the maximum sedimentation volume, which, as stated previously, reflects the amount of flocculation. 312 PHT 22
  • 23. 2. SURFACTANT Both ionic and non-ionic surfactants can be used to bring about flocculation of suspended particles.  Optimum concentration is necessary because these compounds also act as wetting agents to achieve dispersion.  Optimum concentrations of surfactants bring down the surface free energy by reducing the surface tension between liquid medium and solid particles. This tends to form closely packed agglomerates.  The particles possessing less surface free energy are attracted towards to each other by van der-waals forces and forms loose agglomerates. 312 PHT 23
  • 24. 3. POLYMERS Polymers possess long chain in their structures. Starch, alginates, cellulose derivatives, carbomers, tragacanth etc. The part of the long chain is adsorbed on the surface of the particles and remaining part projecting out into the dispersed medium. Bridging between these later portions, also leads to the formation of flocs. 312 PHT 24
  • 25. Viscosity of Suspensions Viscosity of suspensions is of great importance for stability and pourability of suspensions. As we know suspensions have least physical stability amongst all dosage forms due to sedimentation and cake formation. So as the viscosity of the dispersion medium increases, the terminal settling velocity decreases thus the dispersed phase settle at a slower rate and they remain dispersed for longer time yielding higher stability to the suspension. On the other hand as the viscosity of the suspension increases, it’s pourability decreases and inconvenience to the patients for dosing increases. Thus, the viscosity of suspension should be maintained within optimum range to yield stable and easily pourable suspensions. 312 PHT 25
  • 26. Different Approaches To Increase The Viscosity of Suspensions Various approaches have been suggested to enhance the viscosity of suspensions. Few of them are as follows: 1. Viscosity Enhancers Some natural gums (acacia, tragacanth), cellulose derivatives (sodium CMC, methyl cellulose), clays(bentonite, veegum), carbomers, colloidal silicon dioxide (Aerosil), and sugars (glucose, fructose) are used to enhance the viscosity of the dispersion medium. They are known as suspending agents. 312 PHT 26
  • 27. 312 PHT 27 List of Suspending Agents Alginates Methylcellulose Hydroxyethylcellulose Carboxymethylcellulose Sodium Carboxymethylcellulose Microcrystalline cellulose Acacia, Tragacanth, Xanthan gum Bentonite Carbomer Powdered cellulose Gelatin
  • 28. 2. Co-solvents Some solvents which themselves have high viscosity are used as co-solvents to enhance the viscosity of dispersion medium: Glycerol, propylene glycol, sorbitol. Most suspending agents perform two functions i.e. besides acting as a suspending agent they also imparts viscosity to the solution. Suspending agents form film around particle and decrease interparticle attraction. A good suspension should have well developed thixotropy. At rest the solution is sufficient viscous to prevent sedimentation and thus aggregation or caking of the particles. When agitation is applied the viscosity is reduced and provide good flow characteristic from the mouth of bottle. 312 PHT 28
  • 29. Thixotropy Thixotropy is defined as the isothermal slow reversible conversion of gel to sol. Thixotropic substances on applying shear stress convert to sol(fluid) and on standing they slowly turn to gel (semisolid). 312 PHT 29
  • 30. Other Formulation Aspects Introduction A perfect suspension is one, which provides content uniformity. The formulator must encounter important problems regarding particle size distribution, specific surface area, inhibition of crystal growth and changes in the polymorphic form. The formulator must ensure that these and other properties should not change after long term storage and do not adversely affect the performance of suspension. Choice of pH, particle size, viscosity, flocculation, taste, color and odor are some of the most important factors that must be controlled at the time of formulation. Formulation Components The various components, which are used in suspension formulation, are as follows. 312 PHT 30
  • 31. ο‚· Components Function API Active drug substances Wetting agents They are added to disperse solids in continuous liquid phase. Flocculating agents They are added to floc the drug particles Thickeners They are added to increase the viscosity of suspension. Buffers and pH adjusting agents They are added to stabilize the suspension to a desired pH range. Osmotic agents They are added to adjust osmotic pressure comparable to biological fluid. Coloring agents They are added to impart desired color to suspension and improve elegance. Preservatives They are added to prevent microbial growth. External liquid vehicle They are added to construct structure of the final suspension. 312 PHT 31
  • 32. Wetting Agents Hydrophilic materials are easily wetted by water while hydrophobic materials are not. However hydrophobic materials are easily wetted by non-polar liquids. The extent of wetting by water is dependent on the hydrophillicity of the materials. If the material is more hydrophilic it finds less difficulty in wetting by water. Inability of wetting reflects the higher interfacial tension between material and liquid. The interfacial tension must be reduced so that air is displaced from the solid surface by liquid. Non-ionic surfactants are most commonly used as wetting agents in pharmaceutical suspension. Non-ionic surfactants having HLB value between 7-10 are best as wetting agents. High HLB surfactants act as foaming agents. The concentration used is less than 0.5 %. A high amount of surfactant causes solubilization of drug particles and causes stability problem. Ionic surfactants are not generally used because they are not compatible with many adjuvant and causes change in pH. 312 PHT 32
  • 33. Surfactants Surfactants decrease the interfacial tension between drug particles and liquid and thus liquid is penetrated in the pores of drug particle displacing air from them and thus ensures wetting. Surfactants in optimum concentration facilitate dispersion of particles. Generally we use non-ionic surfactants but ionic surfactants can also be used depending upon certain conditions. Disadvantages of surfactants are that they have foaming tendencies. Further they are bitter in taste. Some surfactants such as polysorbate 80 interact with preservatives such as methyl paraben and reduce antimicrobial activity. All surfactants are bitter except Pluronics and Poloxamers. Polysorbate 80 is most widely used surfactant both for parenteral and oral suspension formulation. Polysorbate 80 is also adsorbed on drug particle and decreases its zeta potential. This effect of polysorbate80 stabilizes the suspension. Polysorbate 80 stabilized suspensions through steric mechanism. At low concentration of polysorbate 80,only partial stabilization of suspension was observed. 312 PHT 33
  • 34. Hydrophilic Colloids Hydrophilic colloids coat hydrophobic drug particles in one or more than one layer. This will provide hydrophillicity to drug particles and facilitate wetting. They cause deflocculation of suspension because force of attraction is declined. e.g. acacia, tragacanth, alginates, guar gum, pectin, gelatin, wool fat, egg yolk, bentonite, Veegum, Methylcellulose etc. 312 PHT 34
  • 35. Solvents The most commonly used solvents used are alcohol, glycerin, polyethylene glycol and polypropylene glycol. The mechanism by which they provide wetting is that they are miscible with water and reduce liquid air interfacial tension. Liquid penetrates in individual particle and facilitates wetting. 312 PHT 35
  • 36. Quality Control of Suspensions The following tests are carried out in the final quality control of suspension: Appearance Color, odor and taste Physical characteristics such as particle size determination and microscopic photography for crystal growth Sedimentation rate and Zeta Potential measurement Sedimentation volume Redispersibility and Centrifugation tests Rheological measurement Stress test pH Freeze-Thaw temperature cycling Compatibility with container and cap liner 312 PHT 36
  • 37. Ideal Requirements of Packaging Material It should be inert. It should effectively preserve the product from light, air, and other contamination through shelf life. It should be cheap. It should effectively deliver the product without any difficulty. 312 PHT 37